Ayurcann Holdings Corp.

As of September 30, 2025, Ayurcann Holdings Corp. has 194.70M shares outstanding.

These figures are as of September 30, 2025. The price-to-sales ratio is 0.22, and the price-to-book ratio stands at -1.13.

These figures are as of September 30, 2025. The EV/Sales ratio of 0.21 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Ayurcann Holdings Corp. trades at an EV/FCF ratio of 4.84, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of September 30, 2025, Ayurcann Holdings Corp. maintains a current ratio of 0.61, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -16.46, indicating conservative leverage, while an interest coverage ratio of -4.12 demonstrates limited ability to service its debt obligations.

Over the twelve months ended September 30, 2025, Ayurcann Holdings Corp. posted a negative return on equity (ROE) of -553.55, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -31.26, reflecting losses generated across the asset base. Inventory turnover of 4.81 indicates how many times Ayurcann Holdings Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on April 2, 2026, Ayurcann Holdings Corp.'s stock has declined approximately 66.67% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.02.

Over the twelve months ended September 30, 2025, Ayurcann Holdings Corp. posted a gross margin of 28.92, reflecting its pricing power and cost economics. The operating margin of -10.97 and net profit margin of -14.03 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2025. Free cash flow yield stands at 11.12, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 10.00, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Ayurcann Holdings Corp. shareholders.

Ayurcann Holdings Corp.'s most recent stock split took place on April 8, 2021 with a 2:1 split ratio.

As of September 30, 2025, Ayurcann Holdings Corp. has an Altman Z-Score of -1.07, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.